Novartis is teaming up with the Gates Foundation to develop a gene therapy for sickle cell disease; the World Health Organization reports a drop in global cases of coronavirus disease 2019 (COVID-19); storms hinder vaccine rollout across the United States.
On this episode of Managed Care Cast, we highlight a new feature on AJMC.com, the website of The American Journal of Managed Care®, called Clinical Spotlight, where our editors provide a series of interviews with leading experts in certain specialties.
Novartis' drug, which combines sacubitril and valsartan, is the first to directly treat patients with heart failure with preserved ejection fraction.
The new indication for osimertinib (Tagrisso) marks the first FDA approval of an adjuvant treatment for non–small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations.
Based on positive phase 3 results in adults with idiopathic hypersomnia, Jazz Pharmaceuticals submitted a supplemental new drug application (NDA) to the FDA for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution.
A recent study investigated what makes some non-small cell lung cancer patients with a type of human leukocyte antigen (HLA) called B44 are more likely than others to respond to immunotherapy.
Kicking off the 2021 AcademyHealth National Health Policy Conference, Marcella Nunez-Smith, MD, MHS, stressed the important role that accurate data play in the effort to prioritize health equity during the coronavirus disease 2019 pandemic.
Researchers from the Children’s Medical Center Research Institute at the University of Texas Southwestern discovered a potential treatment for patients with non–small cell lung cancer (NSCLC) who have KRAS and LKB1 mutations.
A global analysis of 9 systematic reviews found a consistent association between vision impairment, eye diseases, and reduced quality of life.
The Affordable Care Act marketplace reopened yesterday for a special enrollment period that will run until May 15; daily US coronavirus infections drop below 100,000 for first time since November; opioid deaths rise significantly amid the pandemic.
Treatment of asthma with biologics was lower for those on public health insurance compared with those who had private insurance, with Blacks underrepresented relative to Whites in publicly insured visits where biologic treatment is used.
Sachin Jain, MD, MBA, FACP, discussed his recent paper that addressed the importance of increased utilization of community health care workers.
An analysis of 30-year data on participants from the Augusta Heart study shows that Black individuals begin to exhibit potential signs of congestive heart failure earlier than their White counterparts.
Patients with ovarian cancer who lived within 10 miles of Kansas’s only National Cancer Institute–designated cancer center, and those of a non-White race, were shown to have less of a survival advantage.
Deferred low-dose computed tomography lung cancer screening during the coronavirus disease 2019 (COVID-19) pandemic has worsened outcomes for patients with lung cancer, a new study found.
The study, presented at the 2020 San Antonio Breast Cancer Symposium, also found that time to first treatment dropped during this period of the coronavirus disease 2019 (COVID-19) pandemic.
Older adults with acute myeloid leukemia (AML) saw increased overall and relapse-free survival, as well as preserved quality of life, following oral administration of 300-mg azacitidine.
The newly approved expanded label includes data from the final analysis of the phase 3 iNNOVATE study of ibrutinib plus rituximab vs rituximab alone.
There is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.
Genentech's tiragolumab, a novel immunotherapy for non-small cell lung cancer with PD-L1 expression, is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation.
British scientists report research linking a UK coronavirus disease 2019 (COVID-19) variant with higher risk of hospitalization and death; polls highlight the partisan gap among Americans willing to be vaccinated against COVID-19; state legislators nationwide are targeting legislation to curb rising drug prices.
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago, discusses the safety and efficacy of spinal muscular atrophy (SMA) treatments.
In addition to coronavirus disease 2019, several other factors will play a major role in health care policy reform for federal and state-level health officials this year, including the transition to value-based care and containment of high health care costs.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Sachin Jain, MD, MBA, FACP, previews some of the topics of discussion for his talk with former HHS Secretary Kathleen Sebelius at the upcoming 2021 Health Datapalooza and National Health Policy Conference.
Nearly 45% of children who underwent diagnostic polysomnography (PSG) for obstructive sleep-disordered breathing were found to have normal sleep studies, warranting greater consideration of PSG to manage adverse sleep symptoms in children and potentially prevent unnecessary surgery.
A recent study found that the proportion of patients in the Netherlands with chronic obstructive pulmonary disease (COPD) who are being assessed for cardiovascular (CV) risk does not align with Dutch guideline recommendations.
Robert K. Massie Jr, PhD, MA, of the Society for Progress, was born with severe factor VIII hemophilia in August 1956. He contracted HIV in 1978 and later hepatitis C, both from contaminated blood products.
Planning and education can help create systemwide change in order to implement greater use of advance care planning and palliative care for those with end-stage renal disease (ESRD).
Fungi within the gut microbiome were not found to be a contributing factor to the initiation and progression of Parkinson disease, contrary to prior findings.
